News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ML Laboratories PLC (LS:MLB) Renews PER.C6 License Agreement With Crucell N.V. (CRXL)


10/19/2005 5:10:27 PM

Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that UK-based ML Laboratories has decided to renew its PER.C6(tm) technology license agreement. Under the renewed agreement, the parties have negotiated research and commercial terms for gene therapy products developed and manufactured on PER.C6(tm) technology. Further details were not disclosed.

Read at Prime Zone

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES